3Gretch DR,Bacchi CE, Corey L Present hepatitis C vires infection after liver transplantation:clinical and virological features. Hepatology,1995,22(1):1-9. 被引量：1
3Reedy KR,Wright TL,Pockros PJ,et al.Efficacy and safety of pegylated (40-kd) interfreon alpha-2a compared with interferon alpha-2a in noncirthotic patients with chronic hepatitis C.Hepatology,2001,33:433-438. 被引量：1
4Moriya K,Yotsuyanagi H,Shintani Y,et al.Hepatitis C virus core protein induces hepatic steatosis in transgen icmice.J Gen Virol,1997;78:1527. 被引量：1
6Heathcote EJ,Shiffman ML,Cooksley WG,et al.Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis.N Engl J Med,2000,343:1673-1680. 被引量：1
7Lindahl K,Stahle L,Bruchfeld A,et al.High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C.Hepatology,2005,41:275-279. 被引量：1
8Kjaergard LL,Krogsgaard K,Gluud C.Interferon alfa with or without ribavirin for chronic hepatitis C:systematic review of randomised trials.BMJ,2001,323:1151-1155. 被引量：1
9Fried MW,Shiffman ML,Reddy KR,et al.Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.N Engl J Med,2002,347:975-982. 被引量：1
10Hadziyannis S J,Sette H Jr,Morgan TR,et al.Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C:a randomized study of treatment duration and ribavirin dose.Ann Intern Med,2004,140:346-355. 被引量：1
